In conclusion, this study unveils a previously unknown complexation event between NPEPPS and LRRC8A proteins, collectively establishing a compelling rationale for targeting NPEPPS to combat cisplatin resistance and enhance chemotherapy efficacy in cancer. The gene discussed is LRRC8A; the disease is cancer.